time savings with paperless validation
default
reduction in test execution time
default
As a biopharmaceutical company focused on developing innovative therapeutics for cancer treatment, a leading health/life sciences company has been providing cutting-edge medical assistance for patients since its inception. With a suite of leading next-generation antibody-based technology platforms, the company is invested in delivering promising life-saving cancer treatments, recognized by its partnerships with several global pharmaceutical and biotechnology companies.
After shifting to independent ownership after a tenure as a global Health Life Sciences (HLS) corporation subsidiary, the company’s IT team found the freedom to explore more agile strategies to power their pursuit of curing life-threatening cancers with an approach that enables quality software innovation at speed.